ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2022

[Chinese Expert Consensus on Management of Special Adverse Effects 
Associated with Lorlatinib].

Qing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.